==== Front Ann Saudi MedAnn Saudi MedAnnals of Saudi Medicine0256-49470975-4466King Faisal Specialist Hospital and Research Centre 2597181810.5144/0256-4947.2014.465asm-6-465Original ArticleThe Saudi Abnormal Glucose Metabolism and Diabetes Impact Study (SAUDI-DM) Al-Rubeaan Khalid aAl-Manaa Hamad bKhoja Tawfik cAhmad Najlaa dAl-Sharqawi Ahmad dSiddiqui Khalid eAlNaqeb Dehkra fAburisheh Khaled aYoussef Amira gAl-Batil Abdullah hAl-Otaibi Metib aAl Ghamdi Ali a a College of Medicine, King Saud University, Riyadh, Saudi Arabia b Ministry of Health, Riyadh, Saudi Arabia c Gulf Cooperation Council, Riyadh, Saudi Arabia d Biostatistics Department, King Saud University, Riyadh, Saudi Arabia e Strategic Center for Diabetes Research, Riyadh, Saudi Arabia f Research Department, King Saud University, Riyadh, Saudi Arabia g Registry Department, King Saud University, Riyadh, Saudi Arabia h Central Department of Statistics and Information, Riyadh, Saudi ArabiaCorrespondence: Khalid Al-Rubeaan, MD, College of Medicine, King Saud University, PO Box 18397, Riyadh 11415, Saudi Arabia, T: +966-11-4786100 ext. 5123, F: +966-11-4775696, krubeaan@dsrcenter.orgNov-Dec 2014 34 6 465 475 Copyright © 2014, Annals of Saudi Medicine2014This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.BACKGROUND AND OBJECTIVES Saudi Arabia underwent opulence-driven socio-cultural and lifestyle changes leading to soaring rates of diabetes mellitus. This study exposes the epidemiology of abnormal glucose metabolism namely: diabetes and impaired fasting glucose (IFG) in 13 administrative regions of Saudi Arabia. DESIGN AND SETTINGS This is a nationwide, household, population-based cross-sectional study that was conducted through primary health care centers during the period 2007–2009. PATIENTS AND METHODS A nationwide, household, population-based cohort of 53 370 participants aged 0–100 years adjusted to be compatible with population census was interviewed and anthropometric measures were collected. Fasting blood sample was used to screen for IFG and diabetes. RESULTS The overall prevalence of abnormal glucose metabolism was 34.5%, which included 22.6% patients with IFG, 11.9% patients with diabetes, and 6.2% patients who unaware of their disease. Diabetes prevalence was 40.2% for subjects aged ≥45 years and 25.4% for those aged ≥30 years that decreased to 11.9% when the full age spectrum was considered. Type 1 diabetes prevalence was 0. 8%, contributing only to 6.6% of the total population of patients with diabetes. The top 5 regions with the highest abnormal glucose metabolism prevalence were Makkah (43.4%), Aljouf (41.7%), Eastern region (37.16%), Madinah (35.4%), and Qassim (33.7%). Urbanization, age, and obesity were behind the wide variations in diabetes and IFG prevalence in the 13 regions. CONCLUSION Abnormal glucose metabolism has reached an epidemic state in Saudi Arabia, where one-third of the population is affected and half of diabetic cases were unaware of their disease. This observation warrants an urgent strategy for launching diabetes primary prevention and screening programs. ==== Body Saudi Arabia is a country known for its wide geographical area and unique homogeneous socio-cultural structure with rapid population growth.1 Over the last 4 decades, this country has passed through a rapid economic development leading to urbanization reflected by life style changes. This life style change has led to soaring rates of chronic diseases, mainly diabetes mellitus, which has put a real challenge to the health system in Saudi Arabia. Over the last 40 years, there have been many studies that looked into this medical problem from different prospective. Fatani et al in 1987, studied diabetes prevalence in the Western province only, and reported the prevalence to be 4.3% in rural areas for people aged ≥15 years, using 1980 World Health Organization (WHO) criteria.2 Al-Nuaim in 1993 calculated diabetes prevalence at a national level to be at 12.5% using 1985 WHO criteria for the age group >15 years.3 It was followed in the national survey by Al-Nozha et al in the year 2004, reporting diabetes prevalence to be at 23.7% using 1997 American Diabetes Association (ADA) criteria in a narrower age group from 30–70 years.4 Since that time, there have been no nationwide or regional studies that have investigated diabetes prevalence using the most recent diagnostic criteria.5 However, there have been many community- or hospital-based studies that reported diabetes prevalence, but these studies lacked a proper sample adjustment or case identification methodology. Other constraints of such studies were limited to either specific age, gender, or diabetes type.6–8 The significant increase in the prevalence of type 2 diabetes mellitus is attributed to the predominance of its risk factors seen in this community. Lifestyle changes, as a result of urbanization and increased affluence, have markedly increased the rates of physical inactivity and obesity.9,10 This was also coupled with socio-cultural changes that have led to high daily caloric intake reflected by the increased consumption of animal products and refined food.11,12 Increased trends in other associated diseases, mainly hypertension and hyperlipidemia, are also contributing to the ever-increasing prevalence of diabetes.13,14 Smoking is another risk factor for diabetes and is becoming even more prevalent in this society.15 Life expectancy for Saudi population has shown a significant increase reaching 75 years in the year 2011,16 which could also play a role in the increased diabetes prevalence. Ethnicity plays a major role for type 2 diabetes susceptibility, wherein Arabs are considered to have high risk of developing type 2 diabetes.17 The high prevalence of diabetes observed in Saudis could be explained on the basis of this ethnicity. Genetic factor has its add on value as a risk factor for type 2 diabetes in this society due to the high prevalence of positive family history and consanguinity rate.18,19 International Diabetes Federation Atlas in its sixth edition in the year 2013 ranked Saudi Arabia the seventh in the top 10 countries known for their high diabetes prevalence, and this position is expected to be the sixth by 2035.20 This observation was based on the previously available epidemiology studies that support this finding and warrant a nationwide study. The Saudi Abnormal Glucose Metabolism and Diabetes Impact Study (SAUDI-DM) was designed to test for the disease prevalence and related risk factors, in addition to its socio-economic impact. This study had looked into the population age at full range and involved the 13 administrative regions of Saudi Arabia in relation to the abnormal glucose metabolism epidemiological characteristics. PATIENTS AND METHODS Study population SAUDI-DM is a nationwide, household population-based cross-sectional study, which was conducted through primary health care centers using a random selection method from the 13 administrative regions in Saudi Arabia during the period from 2007–2009. Trained physicians and nurses had participated in this study by recruiting Saudi national family members from every third house. All family members who were available during that visit were recruited regardless of their age, gender, or clinical status (diabetic or non-diabetic patients), excluding subjects who refused to participate or were not present during the recruitment visit. Data collection Every family member was interviewed and demographic data including age and gender was collected after securing a consent form. Weight, height, and waist circumference were measured for each candidate. Non-diabetic participants were asked to report after more than 10 hours overnight fasting to the primary care center for fasting venous blood sampling after being on regular diet for the last 3 days. A total of 91 564 subjects were captured from the 13 administrative regions. Out of these, 4147 subjects were excluded because of incomplete data—981 subjects had no blood sample, 2077 subjects were without clinical data, and 1089 subjects lacked anthropometric measurements. The remaining 87 417 subjects were adjusted for normal age, gender, and residency area distribution (the residency areas were classified to urban and rural according to the definition given by the Ministry of Municipal and Rural Affairs) to be compatible with the national census of the year 2007 taking in consideration the population distribution in the 13 administrative regions as shown in Table 1. A total 34 047 subjects were excluded during this adjustment phase using the random selection feature in the SPSS (version 17.0, SPSS Inc., Chicago). This technique would eliminate any selection bias that might affect the prevalence rate. The remaining 53 370 subjects after adjustment were used to calculate the national and regional prevalence rate of abnormal glucose metabolism. Participants were classified into 6 age groups that usually shared similar life style, especially diet and physical activity habits. The first group was the preschool group with age ranging from 0–6 years. The second group was from 7–18 years representing the school-age children and adolescents. The third group was from 19–24 years followed by middle age group that ranged from 25–45 years. The fifth group was from 46–65 years, whereas the last group was more than 65 years of age. Laboratory analysis Using vacuum blood-collecting tubes containing sodium fluoride, the fasting whole blood venous samples were collected and stored at −20°C, and transported to the central laboratory of Strategic Center for Diabetes Research in Riyadh. The blood glucose assessment was done using glucose oxidase-peroxidase methodology after separating plasma in a plain tube. Using ADA criteria 2011,21 participants were considered normal if fasting plasma glucose (FPG) was <100 mg/dL (<5.6 mmol/L) and IFG level was between 100 mg/dL (5.6 mmol/L) and 125 mg/dL (6.9 mmol/L), whereas diabetes was considered when the level of FPG was ≥126 mg/dL (7.0 mmol/L). Abnormal glucose metabolism cases in this survey included the known diabetic patients at the time of the survey, in addition to the newly discovered diabetic patients and IFG cases. This study was approved by the Institutional Review Board at the College of Medicine, King Saud University. Statistical analysis Using SPSS, data were represented in descriptive statistics and frequency tables. A P value of <.05 was chosen as the level of significance, t test was used for continuous data, and chi-square test for categorical data. Data was represented as mean and 95% confidence interval (95% CI). The age-adjusted prevalence rate was used to study diabetes prevalence in different age groups using a 5-year interval matched with a 5-year Saudi population pyramid for the year 2007. RESULTS Demographic characteristics A total number of 53 370 participants were stratified for residency areas, out of which 72.5% were living in urban areas and 27.5% in rural areas. Men participants contributed to 48.5%, whereas women contributed to 51.5%. The sample distribution showed that, the largest number of participants were from Makkah, followed by Riyadh and Eastern region, whereas the smallest were from Asir and Northern border as shown in Table 1. Table 2 demonstrates the mean (95% CI) values for age, body mass index (BMI), waist circumference, and FPG of the total sample and for each region. The mean age for the total sample was 25.1 (24.9–25.3) years, which was lower among normal participants (24.2 [23.9–24.4] years), but significantly higher among IFG and diabetic participants (29.6 [29.1–30.1] years and 44.7 [44.2–45.3] years, respectively). The mean BMI for the total sample was 24.3 (24.2–24.4) kg/m2, which was significantly higher among both IFG and diabetic participants. The mean waist circumference for the total sample was 73.8 (73.6–74.0) cm, which was significantly higher among IFG and diabetic participants (80.7 [80.1–81.3] cm and 89.0 [88.4–89.7] cm, respectively). The mean FPG for the total sample was 5.50 (5.47–5.53) mmol/L, whereas it was 6.03 (6.02–6.04) mmol/L for IFG and 9.7 (9.57–9.89) mmol/L for diabetic participants, with a P value <.0001. The highest mean age was found in Asir (27.7 [27.1–28.3] years), whereas the lowest was found in Northern border (23.0 [21.8–24.1] years). The mean BMI was the highest in Tabuk (25.3 [24.9–25.7] kg/m2) and the lowest in Najran at 22.3 (21.9–22.8) kg/m2. The mean waist circumference was found to be the highest in Tabouk at 81.3 (80.3–82.3) cm and the lowest in Aljouf (59.8 [58.3–61.2] cm). The mean FPG was highest in Makkah (5.9 [5.86–6.02] mmol/L), but the lowest in Jizan (4.9 [4.72–4.99] mmol/L). Prevalence of diabetes and IFG Figure 1 demonstrates the Saudi population pyramid from the Census 2007 using 5-year intervals and age-specific diabetes prevalence classified according to the commonly used age ranges. The Saudi population pyramid is following the expansive type that shows a large number of the population in the younger age groups as was observed in most developing countries as a result of high fertility rate (Figure 1B). Figure 1A demonstrates age-specific diabetes prevalence in 5 different age ranges. The overall diabetes prevalence among all age groups (0–100) was 11.9%. The diabetes prevalence increased to 16.7% for the age range between 15 and 100 years and to 22.8% for the age range between 25 and 100 years. Age range between 30 and 100 years had a diabetes prevalence rate of 25.4%, whereas it reached 40.2% when the age range was selected between 45 and 100 years. Age-adjusted prevalence of type 1 diabetes, 2 diabetes, and IFG is shown in Figure 2 according to the selected age groups. The prevalence of type 1 diabetes, type 2 diabetes, and IFG increased with age reaching its peak in the age group more than 65 years at 4.0% for type 1 diabetes, 40.6% for type 2 diabetes, and 29.5% for IFG. For children aged 0–6 years, the prevalence of type 1 diabetes was found to be 0.4%, whereas that of IFG was found to be 2.8%; however, no cases of type 2 diabetes were discovered in this age group. In the age group from 7–18 years, type 1 diabetes remained at 0.4%, whereas type 2 diabetes at 5.2% and IFG at 6.4%, which was almost similar to the age group from 19–24 years at 0.5%, 5.5%, and 6.7% for type 1 diabetes, type 2 diabetes, and IFG, respectively. Abnormal glucose metabolism increased in the age group from 25–45 years, where the prevalence of type 1 diabetes reached 0.8%, type 2 diabetes 11.7%, and IFG 9.5%. This prevalence continued to increase reaching 2.5% for type 1 diabetes, 34.5% for type 2 diabetes, and 13.9% for IFG in the age group from 46–65 years. Regional distribution Table 3 demonstrates the prevalence of different abnormal glucose metabolism, namely, type 1 diabetes, type 2 diabetes, and IFG in various administrative regions for the age group from 0–100 years. The overall prevalence of abnormal glucose metabolism was 34.5%, out of which 22.6% and 11.9% were IFG and diabetes, respectively. Among the diabetic group, the prevalence of type 1 diabetes in the total study sample was 0.8% and that of type 2 diabetes was 11.1%, divided into 4.9% known diabetic patients and 6.2% newly discovered cases. The top 5 regions pertaining to abnormal glucose metabolism were Makkah, Aljouf, Eastern region, Madinah, and Qassim with a prevalence of 43.4% 41.7%, 37.2%, 35.4%, and 33.7%, respectively. These regions also had the highest prevalence of IFG at 27.7%, 29.0%, 24.9%, 21.7%, and 24.4% respectively. Diabetes prevalence was also noted to be high at 15.7%, 12.7%, 12.2%, and 13.7% for Makkah, Aljouf, Eastern region, and Madinah, respectively, but not for Qassim, where diabetes prevalence was 9.3%. Among these top 5 regions, Madinah had the highest prevalence of type 1 diabetes at 1.1%, followed by Makkah at 1.0%, then Eastern region at 0.9%, but lower in Qassim at 0.7% and the lowest in Aliouf at 0.5%. The other group comparatively at a lower rate of abnormal glucose metabolism included Tabuk, Riyadh, Asir, and Bahah with a prevalence rate of 32.0%, 31.0%, 30.7%, and 29.0%, respectively. Among these regions, Tabuk had the highest prevalence of diabetes, whereas Riyadh had the highest prevalence of IFG. Tabuk also demonstrated the highest prevalence rate of type 1 diabetes in the total sample (1.3%), whereas Riyadh demonstrated the lowest type 2 diabetes prevalence in this group (8.9%) but not in the total sample. Bahah region had the lowest prevalence of type 1 diabetes (0.2%) in this group and in the total sample. The lowest prevalence of abnormal glucose metabolism was found in Najran, Northern border, Hail, and Jizan in the same order at 16.1%, 18.8%, 25.8%, and 25.9%, respectively. These regions had the lowest prevalence of IFG, down to 7.4% in Najran, and the lowest prevalence of diabetes reaching 6.6% in Northern border. Type 1 diabetes among these regions was varied being low in Jizan (0.3%) and Northern border (0.3%) and high in Najran (0.8%). Figure 3 shows the map for different administrative regions of Saudi Arabia demonstrating diabetes and IFG prevalence in these regions. IFG prevalence was more than 20% in Aljouf, Makkah, Eastern region, Qassim, Madinah, and Riyadh in the same order, whereas it was less than 20% in Asir, Tabuk, Hail, Bahah, Jizan, Northern border and Najran. Diabetes prevalence was more than 10% in Makkah, Madinah, Tabuk, Aljouf, Eastern region, Bahah, and Asir, but lower than 10% in Jizan, Riyadh, Qassim, Najran, Hail, and Northern border in the same order. DISCUSSION Prevalence of abnormal glucose metabolism Saudi Arabia, in recent times, has been combating against the epidemic of type 2 diabetes mellitus, where 34.5% (11.9% diabetic patients and 22.6% IFG) in all age spectrum of the total population are considered to be suffering from either diabetes or impaired fasting glucose (IFG). It is more prevalent among the targeted age population of 30 years and above, where 1 quarter of this population is already affected with diabetes and another 1 quarter is pre-diabetics in the form of IFG, as was been shown in our previous publication.22 This finding is consistent with what Al-Nozha et al reported in 2004,4 although the use of different diagnostic criteria had its impact on the higher prevalence of IFG observed in the current study. Age plays a significant role in the increased prevalence of diabetes, reaching 40.2% for the people aged 45 years and above in the current study. This observation was also supported by many local and international studies although the prevalence was not as high.2,23,24 Another remarkable observation that was noted from this nationwide study was the unexpected high prevalence of IFG among children at 2.8% and the high prevalence of both type 2 diabetes and IFG between the age group 7 and 18 years at 5.2% and 6.4%, respectively, which is visibly higher than what was reported from other countries.25 This could well be explained by the increased obesity rates in the study cohort accounting for 6.8% in the younger age groups, coupled with high caloric intake and low physical activity reported in this population.26–28 The IFG to diabetes ratio was found to be more than 1 among the population younger than 25 years of age, whereas it was less than 1 among older population. This transformation from IFG to diabetes could be explained on the basis of age progression as shown by other ethnicities.29 The lower IFG to diabetes ratio observed in the people older than 25 years of age could also be explained by frequent exposure to medical checkup in the older population.30,31 The Saudi population pyramid is following the expansive type, where the younger population constitutes more than 50% of the total population. As type 2 diabetes is more prevalent among the middle and old age groups, its prevalence is expected to decrease at the lower age spectrum. In the current study, the prevalence of diabetes for the population aged ≥25 years was found to be 22.8% and would decrease to 16.7% in the population aged 15 years and above. The overall prevalence of diabetes in the entire Saudi population including all age groups was 11.9%, which is considered to be high for a country with more than 50% of its population younger than 20 years of age. Prevalence of type 1 diabetes Type 1 diabetes accounted for just 6.6% of the total diabetic population gradually increased with the progression in age in an accumulative pattern. Its prevalence is 400 cases per 100 000 population in subjects younger than 18 years of age, which is almost 4 times higher than what was reported by Al-Herbish et al in 2008 (109.5 cases per 100 000 population).7 Type 1 diabetes prevalence in the current study has increased 10 times reaching up to 4000 cases per 100 000 population in the age group more than 65 years. This could be explained by the accumulation of cases with age coupled with missed type 1 cases that are diagnosed as type 2 in adolescents and middle-aged people. This increment could also be attributed to the better health care system that increased the life span of type 1 diabetic patients. Regional variations The current study showed the prevalence of abnormal glucose metabolism at a regional level with wide variations ranging from 43.4% in Makkah to 16.1% in Najran, wherein IFG was found to be the most prevalent type at 22.6%, followed by type 2 diabetes at 11.1% and type 1 diabetes at 0.8% in the total population. Makkah, Aljouf, Eastern region, and Madinah showed the highest prevalence of abnormal glucose metabolism exceeding 35%; it was mainly due to the high prevalence of IFG in these regions that had exceeded 20%. This high prevalence could be explained by the fact that they comprise older population or have higher BMI and waist circumference values when compared with the national mean values. In addition, these regions demonstrated higher mean FPG when compared with other administrative regions. Abnormal glucose metabolism prevalence was found to be the lowest in Najran and Northern border with a prevalence rate lesser than 20%. They showed the lowest prevalence of IFG and diabetes, which could be explained by the fact that both these regions had lower mean age and BMI than the total cohort. Their mean FPG was also lower than the mean FPG for the total cohort. The remaining 7 regions had the prevalence of abnormal glucose metabolism between 25.8%% and 33.7% and diabetes between 8.4% and 13.4%. The IFG to type 2 diabetes ratio of 2:1 in the total cohort shows that for each diabetic patient, there are 2 IFG cases. This is also similar to what was reported in Guinea and China.32,33 This ratio was found to be more than 2 in Aljouf, Eastern region, Qassim, Riyadh, and Hail, which could be explained by the increased BMI and decreased mean age in these regions. The type 1 diabetes prevalence varied widely in each region, with the highest in Tabuk at 1.3 % and the lowest in Bahah at 0.2%. This observation was found to be different from what was earlier reported by Al-Herbish et al., where the highest prevalence was observed in Central and Southern provinces and the lowest in Northern and Eastern provinces.7 This difference could be explained on the basis of the different age groups, as his study subjects were between 0 and 19 years of age, whereas ours had no age limitation. When looking at diabetes and IFG distribution in the 13 administrative regions, diabetes prevalence was comparatively higher in Makkah, Madinah, Tabuk, Aljouf, Bahah, Qassim, and Asir, which could be the effect of urbanization in most of these regions as shown in Table 1. On the contrary, it was lower in Jizan and Najran that have more rural areas. Urbanization also played a major role in the high prevalence of IFG in Aljouf, Makkah, Eastern region, Madinah, Qassim, and Riyadh. Comparative analysis with other countries To compare the current study with what was reported earlier from other countries sharing the same socio-economic and life style changes, Table 4 demonstrates diabetes prevalence in the 6 Gulf Cooperation Council (GCC) countries during the period from 1990–2009. The selected 10 studies were all countrywide epidemiological studies using different diagnostic criteria and age groups. Two studies conducted in Saudi Arabia can be compared with our current study; the first one was in 1993 for age group ≥15 years with a calculated prevalence of 12.5% using WHO 1985 criteria.3 The current study that used ADA criteria 2011 for the same cutoff age group, showed an increase in the prevalence of diabetes to 16.7% above 15 years of age. At the same time, the current study demonstrated an increased prevalence rate up to 25.4% for the age group ≥30 years when compared with the second study that was conducted in the year 2000 by Al-Nozha et al who reported a prevalence rate of 23.7% for the age group between 30 and 70 years using ADA 1997 criteria.4 Also 2 studies conducted in Kuwait, 1 in 1999 and another in 1996, both using WHO criteria 1985,34,35 demonstrated that diabetes prevalence has increased from 7.6% to 14.8% for the age group ≥20 years of age, although there was no countrywide epidemiological study in Kuwait after the year 2000 that can be compared with our findings. There was a clear increased trend in the prevalence of diabetes in this country. Oman had 3 epidemiological studies, all for people ≥20 years of age,36–38 where there was an increase in diabetes prevalence from 10% to 16.1% during the period between 1991 and 2002, which is similar to the observed trend in Saudi Arabia. However, the adoption of some diabetes prevention programs in Oman has resulted in an obvious decrease in the prevalence down to 11.6% in 2006, which proves the effectiveness of primary prevention programs in such countries. The only selected study from United Arab Emirates among multiethnic adults ≥20 years showed a prevalence of 20%,39 whereas among the age group 40 to 69 years, diabetes prevalence in Bahrain has reached 30% using WHO 1985 criteria.40 The most recent study from Qatar in 2009 has showed diabetes prevalence to be 16.7% among adults aged ≥20 years.41 Such studies from these 3 countries confirm the same observation of diabetes trend as seen in Saudi Arabia. The rapid economic development in the GCC countries could explain the change in diabetes prevalence trend that has put 3 of them, namely, Saudi Arabia, Kuwait, and Qatar, among the top 10 countries in terms of diabetes prevalence.20 The strength of this study comes from being a countrywide household survey with a large random sample that was adjusted to be compatible with the population census, which could explain the large number of excluded subjects when we were adjusting for age, gender, residency area, and administrative region distribution. Although this study was limited by using only FPG in defining abnormal glucose metabolism cases, it is one of the recommended criteria for diabetes and IFG screening. Another limitation of the current study was the possibility that the enrolled subjects might not have adhered to our instructions of strict overnight fast, especially children and, in particular, those who were in the age group between 0 and 6 years. In conclusion, we found that more than one-third of the total population in all age spectrums was suffering from abnormal glucose metabolism in the form of either diabetes or IFG. More than 50% of these cases were unaware of their disease and were picked up by screening. There is a large variation in IFG and diabetes prevalence in the different regions of Saudi Arabia that can be explained by urbanization, aging, and obesity effect. Although there is an increase in type 1 diabetes prevalence with age, type 2 diabetes and IFG prevalence in Saudi children and adolescents is strikingly higher than what was observed in the region or globally. A primary prevention program in the form of lifestyle modification is sternly needed to stand against this disease epidemic and its heath and economic impact. Acknowledgments The authors would like to acknowledge the staff at the University Diabetes Center for their contribution to the study, and the staff of the primary care centers from the Ministry of Health involved in this study. This study was funded by the University Diabetes Center at King Saud University, Ministry of Health and the Tawuniya Company for health insurance. Disclosure None declared. Figure 1 Age-specific diabetes prevalence in relation to the population pyramid according to the census 2007. Figure 2 Age-adjusted prevalence of type 1 and type 2 diabetes mellitus and impaired fasting glucose according to the age groups. Figure 3 Diabetes and impaired fasting glucose prevalence in the 13 administrative regions in Saudi Arabia. Table 1 The sample stratification and adjustment of the total studied population for all age spectrum distributed by different administrative regions according to gender and residency area. Administrative regionsa Residency areab Gender Total number (%)c Rural (%) Urban (%) Men (%) Women (%) Bahah region 608.0 (73.4) 220.0 (26.6) 395.0 (47.7) 433.0 (52.3) 828.0 (1.6) Aljouf region 296.0 (24.0) 938.0 (76) 636.0 (51.5) 598.0 (48.5) 1234.0 (2.3) Northern border 215.0 (24.5) 663.0 (75.5) 456.0 (51.9) 422.0 (48.1) 878.0 (1.6) Asir region 2736.0 (66.8) 1361.0 (33.2) 1928.0 (47.1) 2169.0 (52.9) 4097.0 (7.7) Hail region 354.0 (24) 1121.0 (76) 687.0 (46.6) 788.0 (53.4) 1475.0 (2.8) Jizan region 1178.0 (42.8) 1575.0 (57.2) 1351.0 (49.1) 1402.0 (50.9) 2753.0 (5.2) Madinah region 1326.0 (38.7) 2099.0 (61.3) 1733.0 (50.6) 1692.0 (49.4) 3425.0 (6.4) Makkah region 1549.0 (13.3) 10 130.0 (86.7) 5599.0 (47.9) 6080.0 (52.1) 11 679.0 (21.9) Najran region 497.0 (36.6) 860.0 (63.4) 652.0 (48) 705.0 (52) 1357.0 (2.5) Qassim region 903.0 (22.7) 3075.0 (77.3) 1940.0 (48.8) 2038.0 (51.2) 3978.0 (7.5) Riyadh region 3284.0 (30.9) 7329.0 (69.1) 5503.0 (51.9) 5110.0 (48.1) 10 613.0 (19.9) Eastern region 1071.0 (11.4) 8286.0 (88.6) 4120.0 (44) 5237.0 (56) 9357.0 (17.5) Tabuk region 635.0 (37.4) 1061.0 (62.6) 873.0 (51.5) 823.0 (48.5) 1696.0 (3.2) Total sample 14 652.0 (27.5) 38 718.0 (72.5) 25 873.0 (48.5) 27 497.0 (51.5) 53 370.0 (100) a There are 13 administrative regions in Saudi Arabia distributed in 5 provinces. b The sample selected according to the national census done in Saudi Arabia by Central Department of Statistics and Information of the Ministry of Planning “Highlights Demographic Survey 1428H (2007)”. c The residency areas were classified to urban and rural according to the definition given by the Ministry of Municipal and Rural Affairs. Table 2 Mean (95%CI) baseline characteristics of total, normal, IFG, and diabetic precipitants aged 0 to 100 y by regions. Total Bahah Aljouf Northern boarder Asir Jizan Najran Riyadh Eastern Qassim Hail Madinah Makkah Tabuk Age (y) Total 25.1 (24.9–25.3) 25.9 (24.6–27.4) 23.1 (22.1–24.1) 23.0 (21.8–24.1) 27.7 (27.1–28.3) 25.7 (25.0–26.4) 23.2 (22.3–24.2) 24.3 (23.9–24.6) 24.6 (24.3–24.9) 24.4 (23.9–24.9) 25.1 (24.0–26.1) 24.9 (24.3–25.6) 25.9 (25.6–26.3) 26.0 (25.3–26.8) Normal 24.2 (23.9–24.4) 26.7 (25.1–28.4) 23.7 (22.4–25.0) 22.7 (21.5–23.9) 24.5 (23.8–25.1) 27.1 (26.0–28.1) 22.7 (21.5–23.9) 24.4 (23.8–24.9) 23.5 (22.9–23.9) 22.9 (22.2–23.6) 24.9 (23.5–26.3) 24.2 (23.3–25.2) 24.8 (24.1–25.4) 22.7 (21.8–23.7) IFG 29.6 (29.1–30.1) 34.6 (30.8–38.4) 27.5 (24.9–30.1) 29.5 (25.6–33.5) 32.4 (30.9–33.9) 32.2 (29.8–34.7) 31.2 (26.3–36.2) 29.5 (28.3–30.7) 27.5 (26.5–28.4) 30.4 (29.1–31.8) 32.2 (28.8–35.6) 32.9 (30.9–34.9) 30.1 (29.1–31.1) 28.5 (26.3–30.7) DM 44.7 (44.2–45.3) 44.6 (40.3–48.8) 45.0 (41.6–48.5) 48.5 (43.2–53.8) 45.3 (43.4–47.3) 44.2 (41.7–46.8) 44.9 (40.7–49.2) 47.6 (46.3–48.8) 41.4 (40.2–42.7) 41.9 (39.9–43.9) 52.6 (49.4–55.8) 48.3 (46.4–50.3) 43.8 (42.7–45.0) 44.9 (42.5–47.4) P value <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 BMI (kg/m2) Total 24.3 (24.2–24.4) 24.0 (23.4–24.6) 24.2 (23.8–24.7) 24.2 (23.6–24.7) 24.2 (23.9–24.4) 23.1 (22.8–23.4) 22.3 (21.9–22.8) 24.7 (24.5–24.9) 24.9 (24.7–25.0) 24.5 (24.3–24.8) 22.8 (22.4–23.2) 22.8 (22.5–23.0) 24.5 (24.3–24.7) 25.3 (24.9–25.7) Normal 24.0 (23.9–24.1) 24.7 (23.8–25.6) 25.5 (24.7–26.3) 24.1 (23.4–24.7) 23.2 (22.9–23.5) 23.5 (23.0–28.1) 22.4 (21.8–22.9) 24.7 (24.3–25.1) 24.4 (24.2–24.7) 24.2 (23.8–24.6) 23.4 (22.8–24.0) 22.7 (22.2–23.1) 24.3 (23.9–24.7) 24.5 (24.0–25.0) IFG 26.3 (26.1–26.6) 26.9 (25.0–28.9) 26.4 (25.3–27.6) 27.7 (25.4–30.0) 26.0 (25.4–26.6) 25.2 (24.2–26.2) 26.6 (23.1–30.0) 26.9 (26.2–27.6) 27.1 (26.6–27.6) 27.0 (26.3v27.7) 25.2 (23.8–26.5) 25.5 (24.6–26.3) 25.9 (25.4–26.4) 27.7 (26.6–28.9) DM 28.7 (28.5–28.9) 28.3 (26.8–29.7) 28.9 (27.7–30.1) 30.5 (28.7–32.3) 28.8 (28.0–29.6) 27.1 (26.4–27.9) 27.1 (25.7–28.5) 29.7 (29.1–30.4) 29.1 (28.5–29.6) 28.8 (28.1–29.8) 28.5 (27.3–29.7) 27.7 (26.9–28.5) 28 (27.7–28.6) 29.3 (28.3–30.3) P value <.0001 .138 .003 .083 <.0001 .001 .545 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 .028 Waist cir. (cm) Total 73.8 (73.6–74.0) 75.7 (74.1–77.3) 59.8 (58.3–61.2) 76.2 (74.9–77.5) 74.3 (73.6–74.9) 72.8 (71.9–73.7) 72.9 (71.7–74.1) 74.0 (73.5–74.6) 78.6 (78.1–79.0) 76.0 (75.3–76.7) 74.9 (73.8–75.9) 71.8 (71.0–72.5) 69.7 (69.2–70.2) 81.3 (80.3–82.3) Normal 74.7 (74.4–75.1) 78.8 (76.9–80.8) 60.2 (57.5–62.8) 78.0 (76.4–79.5) 71.1 (70.3–72.0) 76.2 (74.8–77.5) 72.6 (71.1–74.0) 74.1 (73.1–75.1) 77.7 (76.9–78.5) 75.5 (74.5–76.5) 76.6 (75.0–78.1) 74.1 (72.9–75.3) 74.5 (73.6–75.3) 79.3 (78.0–80.7) IFG 80.7 (80.1–81.3) 84.2 (79.9–88.5) 60.0 (55.1–62.8) 84.8 (80.8–88.9) 79.1 (77.4–80.7) 81.2 (78.5–83.9) 79.9 (75.0–84.8) 80.2 (78.6–81.8) 82.5 (81.1–83.9) 84.7 (83.0–86.4) 84.6 (81.3–87.9) 82.6 (80.0–85.1) 79.9 (78.6–81.1) 87.6 (84.7–90.5) DM 89.0 (88.4–89.7) 91.2 (86.9–95.4) 59.8 (54.3–65.3) 95.0 (91.5–98.6) 87.9 (85.7–90.1) 89.2 (86.5–81.8) 92.8 (89.1–96.4) 92.0 (90.1–93.9) 92.6 (91.0–94.2) 92.7 (90.5–95.0) 95.6 (92.4–98.8) 90.4 (88.0–92.7) 84.3 (83.0–85.7) 93.6 (90.9–96.3) P value <.0001 .015 .814 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 .001 FPG (mmol/L) Total 5.5 (5.5–5.5) 5.2 (5.0–5.3) 5.9 (5.7–6.1) 5.17 (5.1–5.3) 5.4 (5.4–5.5) 4.9 (4.7–5.0) 5.1 (5.0–5.3) 5.4 (5.3–5.5) 5.6 (5.5–5.6) 5.6 (5.5–5.6) 5.3 (5.2–5.5) 5.6 (5.4–5.7) 6.0 (5.9–6.0) 5.3 (5.1–5.4) Normal 4.6 (4.6–4.6) 4.6 (4.5–4.7) 4.7 (4.6–4.7) 4.8 (4.8–4.8) 4.7 (4.6–4.7) 3.9 (3.8–4.0) 4.3 (4.2–4.3) 4.7 (4.7–4.7) 4.76 (4.7–4.8) 4.8 (4.8–4.9) 4.6 (4.5–4.7) 4.3 (4.2–4.4) 4.8 (4.7–4.8) 4.3 (4.2–4.4) IFG 6.0 (6.0–6.0) 6.0 (5.9–6.0) 6.1 (6.1–6.2) 6.0 (5.9–6.0) 6.0 (6.0–6.1) 6.1 (6.0–6.1) 6.1 (6.0–6.2) 6.0 (5.98–6.03) 6.02 (5.99–6.04) 6.0 (5.96–6.02) 6.0 (6.0–6.1) 6.1 (6.0–6.1) 6.1 (6.0–6.1) 6.07 (6.0–6.1) DM 9.7 (9.6–9.9) 7.9 (6.9–8.8) 10.7 (9.8–11.7) 8.6 (7.5–9.7) 10.4 (9.9–10.8) 10.3 (9.6–11.0) 11.0 (10.0–11.9) 9.8 (9.3–10.3) 9.2 (8.8–9.6) 9.2 (8.7–9.7) 10.8 (9.6–12.0) 10.4 (9.8–11.0) 10.2 (9.9–10.6) 10.0 (9.2–10.9) P value <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 CI: Confidence interval; IFG: impaired fasting glucose; DM: diabetes mellitus; BMI: body mass index; Waist circ.: waist circumference; FPG: fasting plasma glucose. P value was calculated between DM and IFG. Table 3 Abnormal glucose metabolism prevalence according to the different types and the administrative regions for age 0 to 100 y. Administrative regions Total sample Number (%) Diabetes mellitus Number (%) IFG Number (%) Total abnormal glucose metabolism Number (%) Type 1 diabetes Type 2 diabetes Total patients with diabetes Known cases New cases Total cases Makkah region 11 679 (21.9) 116 (1.0) 604 (5.2) 1113 (9.5) 1717 (14.7) 1833 (15.7) 3235 (27.7) 5068 (43.4) Aljouf region 1234 (2.3) 6 (0.5) 48 (3.9) 103 (8.3) 151 (12.2) 157 (12.7) 358 (29.0) 515 (41.7) Eastern region 9357 (17.5) 87 (0.9) 576 (6.2) 481 (5.1) 1057 (11.3) 1144 (12.2) 2333 (24.9) 3477 (37.2) Madinah region 3425 (6.4) 36 (1.1) 176 (5.1) 256 (7.5) 432 (12.6) 468 (13.7) 743 (21.7) 1211 (35.4) Qassim region 3978 (7.5) 29 (0.7) 192 (4.8) 150 (3.8) 342 (8.6) 371 (9.3) 971 (24.4) 1342 (33.7) Tabuk region 1696 (3.2) 22 (1.3) 117 (6.9) 88 (5.2) 205 (12.1) 227 (13.4) 316 (18.6) 543 (32.0) Riyadh region 10 613 (19.9) 63 (0.6) 456 (4.3) 488 (4.6) 944 (8.9) 1007 (9.5) 2281 (21.5) 3288 (31.0) Asir region 4097 (7.7) 25 (0.6) 154 (3.8) 289 (7.1) 443 (10.8) 468 (11.4) 791 (19.3) 1259 (30.7) Bahah region 828 (1.6) 2 (0.2) 69 (8.3) 25 (3.0) 94 (11.4) 96 (11.6) 144 (17.4) 240 (29.0) Jizan region 2753 (5.2) 9 (0.3) 97 (3.5) 162 (5.9) 259 (9.4) 268 (9.7) 446 (16.2) 714 (25.9) Hail region 1475 (2.8) 9 (0.6) 73 (5.0) 42 (2.9) 115 (7.8) 124 (8.4) 257 (17.4) 381 (25.8) Northern border 878 (1.6) 3 (0.3) 22 (2.5) 33 (3.8) 55 (6.3) 58 (6.6) 107 (12.2) 165 (18.8) Najran region 1357 (2.5) 11 (0.8) 53 (3.9) 54 (4.0) 107 (7.9) 118 (8.7) 101 (7.4) 219 (16.1) Total country 53 370 (100) 418 (0.8) 2637 (4.9) 3284 (6.2) 5921 (11.1) 6339 (11.9) 12 083 (22.6) 18 422 (34.5) IFG: Impaired fasting glucose. Table 4 Diabetes prevalence from the country-wide epidemiological studies in the 6 GCC countries during the period between 1990 and 2009. Country Authors Year Sample size Age group (years) Diagnostic criteria Prevalence of diabetes Ref. Saudi Arabia Al-Nuaim 1997 13 177 ≥15 WHO criteria 1985 12.5% [3] Al-Nozha et al 2004 17 232 30–70 ADA criteria 1997 23.7% [4] Al-Rubeaan et al 2015 53 370 ≥15 ADA criteria 2011 16.7% Current ≥30 25.4% Kuwait Abdella et al 1996 261 387 ≥20 WHO criteria 1985 7.6% [34] Abdella et al 1998 3003 ≥20 WHO criteria 1985 14.8% [35] Oman Asfour et al 1995 5096 ≥20 WHO criteria 1985 10% [36] Al-Lawati et al 2002 5838 ≥20 WHO criteria 1999 16.1% [37] Al-Moosa et al 2006 7179 ≥20 WHO criteria 2000 11.6% [38] United Arab Emirates Malik et al 2005 5844 ≥20 WHO criteria 1999 20% [39] Bahrain Al-Mahroos et al 2001 2013 40–69 WHO criteria 1985 30% [40] Qatar Bener et al 2009 1117 ≥20 WHO expert group 2006 16.7% [41] ==== Refs REFERENCES 1 Central Department of Statistics Riyadh, Saudi Arabia 2003 [AUTHOR: The first reference is not complete. Please provide complete bibliographic details.] 2 Fatani HH Mira SA el-Zubier AG Prevalence of diabetes mellitus in rural Saudi Arabia Diabetes Care 1987 4 10 2 180 3 3582078 3 Al-Nuaim AR Prevalence of glucose intolerance in urban and rural communities in Saudi Arabia Diabet Med 1997 7 14 7 595 602 9223399 4 Al-Nozha MM Al-Maatouq MA Al-Mazrou YY Al-Harthi SS Arafah MR Khalil MZ Khan NB Al-Khadra A Al-Marzouki K Nouh MS Abdullah M Attas O Al-Shahid MS Al-Mobeireek A Diabetes mellitus in Saudi Arabia Saudi Med J 2004 11 25 11 1603 10 15573186 5 Genuth S Alberti KGMM Bennett P Buse J Defronzo R Kahn R Kitzmiller J Knowler WC Lebovitz H Lernmark A Nathan D Palmer J Rizza R Saudek C Shaw J Steffes M Stern M Tuomilehto J Zimmet P Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 2003 11 26 11 3160 7 14578255 6 Alqurashi KA Aljabri KS Bokhari SA Prevalence of diabetes mellitus in a Saudi community Ann Saudi Med 2011 2 31 1 19 23 21245594 7 Al-Herbish AS El-Mouzan MI Al-Salloum AA Al-Qurachi MM Al-Omar AA Prevalence of type 1 diabetes mellitus in Saudi Arabian children and adolescents Saudi Med J 2008 9 29 9 1285 8 18813413 8 Al-Quwaidhi AJ Pearce MS Sobngwi E Critchley JA O’Flaherty M Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies Diabetes Res Clin Pract 2014 3 103 3 496 503 24447810 9 Al-Nozha MM Al-Hazzaa HM Arafah MR Al-Khadra A Al-Mazrou YY Al-Maatouq MA Khan NB Al-Marzouki K Al-Harthi SS Abdullah M Al-Shahid MS Prevalence of physical activity and inactivity among Saudis aged 30–70 years. A population-based cross-sectional study Saudi Med J 2007 4 28 4 559 68 17457478 10 Al-Nozha MM Al-Mazrou YY Al-Maatouq MA Arafah MR Khalil MZ Khan NB Al-Marzouki K Abdullah MA Al-Khadra AH Al-Harthi SS Al-Shahid MS Al-Mobeireek A Nouh MS Obesity in Saudi Arabia Saudi Med J 2005 5 26 5 824 9 15951877 11 Amin TT Al-Sultan AI Ali A Overweight and Obesity and their Association with Dietary Habits, and Sociodemographic Characteristics Among Male Primary School Children in Al-Hassa, Kingdom of Saudi Arabia Indian J Community Med 2008 7 33 3 172 81 19876479 12 Mahfouz AA Abdelmoneim I Khan MY Daffalla AA Diab MM Al-Gelban KS Moussa H Obesity and related behaviors among adolescent school boys in Abha City, Southwestern Saudi Arabia J Trop Pediatr 2008 4 54 2 120 4 18039676 13 Al-Nozha MM Abdullah M Arafah MR Khalil MZ Khan NB Al-Mazrou YY Al-Maatouq MA Al-Marzouki K Al-Khadra A Nouh MS Al-Harthi SS Al-Shahid MS Al-Mobeireek A Hypertension in Saudi Arabia Saudi Med J 2007 1 28 1 77 84 17206295 14 Al-Nozha MM Arafah MR Al-Maatouq MA Khalil MZ Khan NB Al-Marzouki K Al-Mazrou YY Abdullah M Al-Khadra A Al-Harthi SS Al-Shahid MS Al-Mobeireek A Nouh MS Hyperlipidemia in Saudi Arabia Saudi Med J 2008 2 29 2 282 7 18246242 15 Bassiony MM Smoking in Saudi Arabia Saudi Med J 2009 7 30 7 876 81 19617999 16 The World Bank Life expectancy at birth [Internet] 2011 [cited 2014 Dec 23]. Available from: http://data.worldbank.org/indicator/SP.DYN.LE00.IN?order=wbapi_data_value_2011+wbapi_data_value+wbapi_data_value-last&sort=asc,/ 17 Al-Rubeaan K Siddiqui K Saeb ATM Nazir N Al-Naqeb D Al-Qasim S ACE I/D and MTHFR C677T polymorphisms are significantly associated with type 2 diabetes in Arab ethnicity: a meta-analysis Gene 2013 5 15 520 2 166 77 23458876 18 Bener A Hussain R Teebi AS Consanguineous marriages and their effects on common adult diseases: studies from an endogamous population Med Princ Pract 2007 16 4 262 7 17541290 19 Al-Gazali L Hamamy H Al-Arrayad S Genetic disorders in the Arab world BMJ 2006 10 21 333 7573 831 4 17053236 20 International Diabetes Federation IDF Diabetes Atlas [Internet] 6th ed Brussels, Belgium International Diabetes Federation 2013 Available from: http://www.idf.org/diabetesatlas 21 American Diabetes Association Standards of medical care in diabetes--2011 Diabetes Care 2011 1 34 Suppl 1 S11 61 21193625 22 Al-Rubeaan K Al-Manaa HA Khoja TA Ahmad NA Al-Sharqawi AH Siddiqui K Alnaqeb D Aburisheh KH Youssef AM Al-Batel A Alotaibi MS Al-Gamdi AA Epidemiology of abnormal glucose metabolism in a country facing its epidemic: SAUDI-DM study J Diabetes 2014 9 30 25266306 23 Ramachandran A Snehalatha C Kapur A Vijay V Mohan V Das AK Rao PV Yajnik CS Prasanna Kumar KM Nair JD Diabetes Epidemiology Study Group in India (DESI) High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey Diabetologia 2001 9 44 9 1094 101 11596662 24 Lindstrom J Tuomilehto J The diabetes risk score: a practical tool to predict type 2 diabetes risk Diabetes Care 2003 3 26 3 25 731 12610029 25 Clark NG Fox KM Grandy S SHIELD Study Group Symptoms of diabetes and their association with the risk and presence of diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD) Diabetes Care 2007 11 30 11 2868 73 17712027 26 Ebbeling CB Pawlak DB Ludwig DS Childhood obesity: public-health crisis, common sense cure Lancet 2002 8 10 360 9331 473 82 12241736 27 Al-Hazzaa HM Abahussain NA Al-Sobayel HI Qahwaji DM Musaiger AO Physical activity, sedentary behaviors and dietary habits among Saudi adolescents relative to age, gender and region Int J Behav Nutr Phys Act 2011 8 140 22188825 28 Collison KS Zaidi MZ Subhani SN Al-Rubeaan K Shoukri M Al-Mohanna FA Sugar-sweetened carbonated beverage consumption correlates with BMI, waist circumference, and poor dietary choices in school children BMC Public Health 2010 10 234 20459689 29 Al-Hazzaa HM Al-Rasheedi AA Adiposity and physical activity levels among preschool children in Jeddah, Saudi Arabia Saudi Med J 2007 5 28 5 766 73 17457449 30 Khambalia A Phongsavan P Smith BJ Keke K Dan L Fitzhardinge A Bauman AE Prevalence and risk factors of diabetes and impaired fasting glucose in Nauru BMC Public Health 2011 11 719 21943388 31 Esteghamati A Etemad K Koohpayehzadeh J Abbasi M Meysamie A Noshad S Asgari F Mousavizadeh M Rafei A Khajeh E Neishaboury M Sheikhbahaei S Nakhjavani M Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011 Diabetes Res Clin Pract 2014 2 103 2 319 27 24447808 32 Balde N-M Diallo I Balde M-D Barry I-S Kaba L Diallo M-M Kake A Camara A Bah D Barry M-M Sangare-Bah M Maugendre D Diabetes and impaired fasting glucose in rural and urban populations in Futa Jallon (Guinea): prevalence and associated risk factors Diabetes Metab 2007 4 33 2 114 20 17363316 33 Hao C Zhang C Chen W Shi Z Prevalence and risk factors of diabetes and impaired fasting glucose among university applicants in Eastern China: findings from a population-based study Diabet Med 2014 10 31 10 1194 8 24766092 34 Abdella N Khogali M al-Ali S Gumaa K Bajaj J Known type 2 diabetes mellitus among the Kuwaiti population. A prevalence study Acta Diabetol 1996 7 33 2 145 9 8870817 35 Abdella N Al Arouj M Al Nakhi A Al Assoussi A Moussa M Non-insulin-dependent diabetes in Kuwait: prevalence rates and associated risk factors Diabetes Res Clin Pract 1998 12 42 3 187 96 9925350 36 Asfour MG Lambourne A Soliman A Al-Behlani S Al-Asfoor D Bold A Mahtab H King H High prevalence of diabetes mellitus and impaired glucose tolerance in the Sultanate of Oman: results of the 1991 national survey Diabet Med 1995 12 12 12 1122 5 8750224 37 Al-Lawati JA Al Riyami AM Mohammed AJ Jousilahti P Increasing prevalence of diabetes mellitus in Oman Diabet Med 2002 11 19 11 954 7 12421434 38 Al-Moosa S Allin S Jemiai N Al-Lawati J Mossialos E Diabetes and urbanization in the Omani population: an analysis of national survey data Popul Health Metr 2006 4 5 16635266 39 Malik M Bakir A Saab BA Roglic G King H Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates: results of a national survey Diabetes Res Clin Pract 2005 8 69 2 188 95 16005369 40 Al-Mahroos F Al-Roomi K Obesity among adult Bahraini population: impact of physical activity and educational level Ann Saudi Med 2001 7 21 3–4 183 7 17264547 41 Bener A Zirie M Janahi IM Al-Hamaq AOAA Musallam M Wareham NJ Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar Diabetes Res Clin Pract 2009 4 84 1 99 106 19261345